ADvantage Therapeutics, Inc. — Form D

ADvantage Therapeutics, Inc. of Miami, FL, a company, filed a Form D exempt-offering notice with the SEC on 2022-06-15. The offering totals $7.5M, of which $275K was reported sold. Industry: Other Health Care.

Offering

• Filed: 2022-06-15
• Form: D
• Accession: 0001869338-22-000001
• Industry: Other Health Care
• Exemptions: 06b
• Total offering: $7.5M
• Amount sold: $275K
• Remaining: $7.2M
• Investors: 3
• Date of first sale: 2022-05-31
• Revenue range: Decline to Disclose
• SEC file number: 021-449324

Issuer

• Name: ADvantage Therapeutics, Inc.
• CIK: 0001869338
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2021
• Address: 195 NW 40th Street, Miami, FL, 33140
• Phone: 630-886-7345

Officers, directors & promoters (8)

Other filings by this issuer (3)

More

• CIK 1869338 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search